Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 2/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.53 |
| ▸ | MIF | P14174 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 1/20 | 0.53 |
| ▸ | HTR2B | P41595 | 1/20 | 0.53 |
| ▸ | KYNU | Q16719 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.46 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.46 |
| ▸ | DRD1 | P21728 | 1/20 | 0.46 |
| ▸ | HTR7 | P34969 | 1/20 | 0.46 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30839508 | 0.84 | ADRB1 (0.50) | ADRB1ADRA1AMIFHTR2AHTR2B | |
| SCHEMBL27199248 | 0.84 | ADRB1 (0.50) | ADRB1ADRA1AMIFHTR2AHTR2B | |
| SCHEMBL15157484 | 0.82 | ADRB1 (0.56) | ADRB1ADRA1AMIFHTR2AHTR2B | |
| SCHEMBL16511750 | 0.82 | ADRB1 (0.52) | ADRB1ADRA1AMIFHTR2AHTR2B | |
| SCHEMBL633773 | 0.82 | ADRB1 (0.56) | ADRB1ADRA1AMIFHTR2AHTR2B | |
| Phenol SCHEMBL28231638 | 0.81 | CA12 (0.48) | LMNACA12ALDH1A1CA2CA9 | |
| Hydrochloric Acid SCHEMBL4931729 | 0.80 | ADRB1 (0.55) | ADRB1ADRA1AMIFHTR2AHTR2B | |
| SCHEMBL3617955 | 0.79 | GBA1 (0.48) | TSHRLMNAALDH1A1OPRK1KMT2A | |
| SCHEMBL14147014 | 0.79 | CPN1 (0.47) | ADRB1ADRA1AMIFHTR2AHTR2B | |
| SCHEMBL3446697 | 0.79 | GBA1 (0.48) | TSHRLMNAALDH1A1OPRK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12594280-B2 | Antiviral compositions for treating the flu | UNIVERSITE CLAUDE BERNARD LYON 1 (FR) | 2026-04-07 | — | — | US | disclosed |
| EP-3270968-B1 | NOVEL ANTIVIRAL COMPOSITIONS FOR TREATING THE FLU | UNIV CLAUDE BERNARD LYON (FR) | 2024-03-06 | — | — | EP | disclosed |
| US-20220296606-A1 | NOVEL ANTIVIRAL COMPOSITIONS FOR TREATING THE FLU | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2022-09-22 | — | — | US | disclosed |
| US-11351180-B2 | Antiviral compositions for treating the flu | UNIVERSITE CLAUDE BERNARD LYON 1 (FR) | 2022-06-07 | — | — | US | disclosed |
| CN-113876781-A | Novel antiviral compositions for the treatment of influenza | 里昂第一大学 | 2022-01-04 | — | — | CN | disclosed |
| US-20180042937-A1 | NOVEL ANTIVIRAL COMPOSITIONS FOR TREATING THE FLU | HOSPICES CIVILS DE LYON (FR) | 2018-02-15 | — | — | US | disclosed |
| EP-3270968-A2 | NOVEL ANTIVIRAL COMPOSITIONS FOR TREATING THE FLU | Université Claude Bernard Lyon 1 (FR) | 2018-01-24 | — | — | EP | disclosed |
| WO-2016146836-A2 | NOVEL ANTIVIRAL COMPOSITIONS FOR TREATING THE FLU | UNIVERSITE CLAUDE BERNARD LYON 1 (FR) | 2016-09-22 | — | — | WO | disclosed |
| EP-0182279-B1 | PROCESS FOR THE OPTICAL RESOLUTION OF RACEMIC MIXTURES OF ALPHA-NAPHTYL-PROPIONIC ACIDS | ALFA WASSERMANN S.p.A. (IT) | 1990-02-28 | — | — | EP | disclosed |
| US-4661628-A | Process for the optical resolution of racemic mixtures of α-naphthyl-propionic acids | ALFA CHEMICALS ITALIANA S.P.A. (IT) | 1987-04-28 | — | — | US | disclosed |
| US-4622419-A | AMIDATION, ACID HYDROLYSIS | ALFA CHEMICALS ITALIANA S.P.A. (IT) | 1986-11-11 | — | — | US | disclosed |
| EP-0182279-A1 | Process for the optical resolution of racemic mixtures of alpha-naphtyl-propionic acids | ALFA WASSERMANN S.p.A. (IT) | 1986-05-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12594280-B2 | Antiviral compositions for treating the flu | CHRM1, CHRM2, CHRM3 | ADRB1 19/4885ADRA1A 23/4885MIF 768/4885 |
| US-20220296606-A1 | NOVEL ANTIVIRAL COMPOSITIONS FOR TREATING THE FLU | ETFA, TNNC1, PIGS | ADRB1 17/4885ADRA1A 47/4885MIF 225/4885 |
| US-20180042937-A1 | NOVEL ANTIVIRAL COMPOSITIONS FOR TREATING THE FLU | ETFA, TNNC1, TNNT2 | ADRB1 17/4885ADRA1A 46/4885MIF 211/4885 |
| US-11351180-B2 | Antiviral compositions for treating the flu | ETFA, PIGS, TNNT2 | ADRB1 28/4885ADRA1A 90/4885MIF 262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.